by Stacey Johnson | Jun 2, 2023
The Networks of Centres of Excellence (NCE) program has been on my mind lately. Yes it’s true, although it may seem odd to admit. The Government of Canada’s innovative program, launched in 1989, was intended to “mobilize Canada’s best research, development and...
by Cal Strode | May 18, 2023
Regular readers of Alliance for Regenerative Medicine (ARM) sector reports may have noticed that the organization is taking a new approach to sharing insights on the cell and gene therapy sector. In April, ARM launched a new format for distilling key data and trend...
by Cal Strode | Mar 29, 2023
Few people have made bigger contributions to the Canadian regenerative medicine ecosystem than Dr. Peter Zandstra. He is co-founder of two companies advancing cutting-edge biotechnologies for therapeutic use (Notch Therapeutics and ExCellThera, both of which are...
by Stacey Johnson | Feb 11, 2023
Have you heard of Henrietta Leavitt, Annie Cannon and Williamina Fleming? They are to astronomy what Katherine Johnson, Dorothy Vaughan and Mary Jackson are to NASA and the space race. If the latter three names are familiar, you probably saw the movie Hidden Figures,...
by Stacey Johnson | Jan 27, 2023
Last year saw the organizers behind Advanced Therapies Week (ATW) move the conference from Miami to Miami Beach to accommodate a larger audience. As the Covid-19 pandemic was still going strong in January 2022, making international travel more difficult, attendance...
by Cal Strode | Jan 12, 2023
The Alliance for Regenerative Medicine (ARM) delivered its State of the Industry Briefing (#CGSOTI23) at Biotech Showcase, held January 9–11, 2023, in San Francisco, California. Tim Hunt, CEO, of the Alliance for Regenerative Medicine (ARM) kicked things off by...
Comments